C5 - complement C5 Gene

Also Known as C5D; C5a; C5b; ECLZB; CPAMD4

Species: Homo sapiens

Gene Type: protein coding
Gene ID: 727

About C5

Cytogenetic location: 9q33.2 Genomic coordinates (GRCh38): 9:120,952,335-121,074,865 (from NCBI)

This gene has 13 transcripts (splice variants), 196 orthologues, 8 paralogues and is associated with 3 phenotypes. Biased expression in liver (RPKM 85.9) and lung (RPKM 3.7).

Summary

This gene encodes a component of the Complement System, a part of the innate immune system that plays an important role in inflammation, host homeostasis, and host defense against pathogens. The encoded preproprotein is proteolytically processed to generate multiple protein products, including the C5 alpha chain, C5 beta chain, C5a anaphylatoxin and C5b. The C5 protein is comprised of the C5 alpha and beta chains, which are linked by a disulfide bridge. Cleavage of the alpha chain by a convertase enzyme results in the formation of the C5a anaphylatoxin, which possesses potent spasmogenic and chemotactic activity, and the C5b macromolecular cleavage product, a subunit of the membrane attack complex (MAC). Mutations in this gene cause Complement Component 5 deficiency, a disease characterized by recurrent Bacterial infections. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Nov 2015]

C5 Products (3)

mRNA Protein Name
NM_001317163.2 NP_001304092.1 complement C5 isoform 2
NM_001317164.2 NP_001304093.1 complement C5 isoform 3 precursor
NM_001735.3 NP_001726.2 complement C5 isoform 1 preproprotein

Gene Ontology

  • Molecular Function
  • Biological Process
  • Cellular Component
Molecular Function GO Annotation Evidence References Source
enables protein binding IPI
IPI: Inferred from physical interaction
19528535 GOA
Biological Process GO Annotation Evidence References Source
involved in negative regulation of macrophage chemotaxis IDA
IDA: Inferred from direct assay
14566334 GOA
involved in positive regulation of chemokine production IDA
IDA: Inferred from direct assay
14566334 GOA
involved in positive regulation of vascular endothelial growth factor production IDA
IDA: Inferred from direct assay
14566334 GOA
Cellular Component GO Annotation Evidence References Source
part of membrane attack complex IDA
IDA: Inferred from direct assay
22832194 GOA
EXP: Inferred from Experiment IDA: Inferred from direct assay IPI: Inferred from physical interaction IMP: Inferred from mutant phenotype IGI: Inferred from genetic interaction IEP: Inferred from expression pattern

C5 Protein Structure

A2M_N

A2M_N: MG2 domain (126 - 219)

A2M_N_2

A2M_N_2: Alpha-2-macroglobulin family N-terminal region (473 - 610)

ANATO

ANATO: Anaphylotoxin-like domain (698 - 732)

A2M

A2M: Alpha-2-macroglobulin family (772 - 859)

A2M_comp

A2M_comp: A-macroglobulin complement component (1052 - 1301)

A2M_recep

A2M_recep: A-macroglobulin receptor (1419 - 1509)

NTR

NTR: UNC-6/NTR/C345C module (1551 - 1658)

  • 0
  • 300
  • 600
  • 900
  • 1200
  • 1500
  • 1676 a.a.
Protein Preferred Names Protein Names

complement C5

  • C3 and PZP-like alpha-2-macroglobulin domain-containing protein 4

C5 Protein-protein interaction Information

Type
Protein Name Protein ID Interactor Interactor Species Interactor ID Detection Method References
Intra
C5 P01031 PGRMC2 Homo sapiens O15173
Y2H Array
32296183
Intra
C5 P01031 PGRMC2 Homo sapiens O15173
Y2H Prey Pooling
32296183
Intra
C5 P01031 NEMP1 Homo sapiens O14524-2
Y2H Array
32296183
Intra
C5 P01031 NEMP1 Homo sapiens O14524-2
Y2H Prey Pooling
32296183
Intra
C5 P01031 POU6F2 Homo sapiens P78424
Y2H Prey Pooling
32296183
Intra
C5 P01031 POU6F2 Homo sapiens P78424
Validated Y2H
32296183
Intra
C5 P01031 POU6F2 Homo sapiens P78424
Y2H Array
32296183
Intra
C5 P01031 AQP6 Homo sapiens Q13520
Y2H Prey Pooling
32296183
Intra
C5 P01031 AQP6 Homo sapiens Q13520
Validated Y2H
32296183
Intra
C5 P01031 AQP6 Homo sapiens Q13520
Y2H Array
32296183
Intra
C5 P01031 KIR3DL3 Homo sapiens Q8N743
Validated Y2H
32296183
Intra
C5 P01031 KIR3DL3 Homo sapiens Q8N743
Y2H Array
32296183
Intra
C5 P01031 KIR3DL3 Homo sapiens Q8N743
Y2H Prey Pooling
32296183
Intra
C5 P01031 SSMEM1 Homo sapiens Q8WWF3
Y2H Array
32296183
Intra
C5 P01031 SSMEM1 Homo sapiens Q8WWF3
Validated Y2H
32296183
Intra
C5 P01031 SSMEM1 Homo sapiens Q8WWF3
Y2H Prey Pooling
32296183
Intra
C5 P01031 CPLX4 Homo sapiens Q7Z7G2
Validated Y2H
32296183
Intra
C5 P01031 CPLX4 Homo sapiens Q7Z7G2
Y2H Array
32296183
Intra
C5 P01031 CPLX4 Homo sapiens Q7Z7G2
Y2H Prey Pooling
32296183
Intra
C5 P01031 EBP Homo sapiens Q15125
Y2H Prey Pooling
32296183
Intra
C5 P01031 EBP Homo sapiens Q15125
Validated Y2H
32296183
Intra
C5 P01031 EBP Homo sapiens Q15125
Y2H Array
32296183
Intra
C5 P01031 CFHR1 Homo sapiens Q03591
Anti Bait CoIP
19528535
Intra
C5 P01031 CFHR1 Homo sapiens Q03591
SPR
19528535
Intra
C5 P01031 MMGT1 Homo sapiens Q8N4V1
Y2H Prey Pooling
32296183
Intra
C5 P01031 MMGT1 Homo sapiens Q8N4V1
Validated Y2H
32296183
Intra
C5 P01031 MMGT1 Homo sapiens Q8N4V1
Y2H Array
32296183
Intra
C5 P01031 CREB3L1 Homo sapiens Q96BA8
Validated Y2H
25416956
Intra
C5 P01031 ANKS6 Homo sapiens Q68DC2
Y2H Array
32296183
Intra
C5 P01031 ANKS6 Homo sapiens Q68DC2
Y2H Prey Pooling
32296183
Intra
C5 P01031 ANKS6 Homo sapiens Q68DC2
Validated Y2H
32296183
Cross
C5 P01031 vco3_najka Naja kaouthia Q91132
X-Ray Diffraction
21217642
Intra
C5 P01031 KEL Homo sapiens P23276
Y2H Array
32296183
Intra
C5 P01031 KEL Homo sapiens P23276
Y2H Prey Pooling
32296183
Intra
C5 P01031 KEL Homo sapiens P23276
Validated Y2H
32296183
Cross: Cross-species interaction Intra: Intraspecies interaction

Recombinant C5 Proteins

Cat. No. Product Name Accession Purity
HY-P7864 Complement C5a Protein, Human P01031 (T678-R751) ≥ 95%, as determined by reducing SDS-PAGE.
HY-P700862 Complement C5 Protein, Human (HEK293, His) P01031 (Q19-C1676) ≥ 95%, as determined by Bis-Tris PAGE.
HY-P700959 Complement C5a Protein, Human (His) P01031 (T678-R751) ≥ 90%, as determined by reducing SDS-PAGE.

C5 Antibodies

Cat. No. Product Name Application Reactivity
HY-P81185 C5b-9 Antibody WB, IHC-P, IHC-F, ICC/IF Human, Rat
HY-P86840 Complement C5 Antibody (YA6533) WB, ICC/IF, IHC-P, FC Human

Related Diseases

Diseases Alias
Complement Component 5 Deficiency

  • C5 Deficiency

  • C5D
Eculizumab, Poor Response To
Leiner Disease

  • Erythroderma Desquamativum

  • Complement Component 5 Deficiency
Immunodeficiency Due To A Late Component Of Complement Deficiency

  • Immunodeficiency Due To C5 To C9 Component Complement Deficiency

  • Terminal Complement Pathway Deficiency
Complement Deficiency

  • Complement Deficiency Disease

  • Hereditary Complement Deficiency Diseases
Acute Poststreptococcal Glomerulonephritis

  • Post-Streptococcal Glomerulonephritis

  • Acute Post-Streptococcal Glomerulonephritis
Hemoglobinuria
Hemolytic-Uremic Syndrome

  • Hemolytic Uremic Syndrome

  • Haemolytic-Uraemic Syndrome

  • Hus

  • Acute Renal Failure, Thrombocytopenia, And Microangiopathic Hemolytic Anemia Associated With Distorted Erythrocytes

  • Typical Haemolytic Uraemic Syndrome

  • Gasser Syndrome

  • Hus - [Haemolytic Uraemic Syndrome]
Meningoencephalitis

  • Acquired Toxoplasmal Meningoencephalitis

  • Meningoencephalitis Due To Acquired Toxoplasmosis

  • Meningoencephalitis Due To Toxoplasmosis

  • Toxoplasma Meningoencephalitis
Hellp Syndrome

  • Hemolysis, Elevated Liver Enzymes, Lowered Platelets

  • Hemolysis, Elevated Liver Enzymes, Low Platelets In Pregnancy

  • Hemolysis-Elevated Liver Enzymes-Low Platelets Syndrome

  • Hellp - [Syndrome Of Haemolysis, Elevated Liver Enzymes And Low Platelet]

  • Haemolysis-Elevated Liver Enzymes-Low Platelet Count Syndrome
Hemolytic Uremic Syndrome, Atypical 1

  • Atypical Hemolytic-Uremic Syndrome

  • Hemolytic Uremic Syndrome, Atypical, Susceptibility To, 1

  • Atypical Hemolytic Uremic Syndrome

  • Hemolytic Uremic Syndrome, Atypical, Susceptibility To

  • Ahus

  • AHUS1

  • Hemolytic-Uremic Syndrome

  • Ahus 1

  • Ahus, Susceptibility To, 1

  • Hemolytic Uremic Syndrome, Atypical

  • Non-Shiga-Like Toxin-Associated Hus

  • Non-Stx-Hus

  • Nonenteropathic Hus

  • Atypical Hus

  • Shiga Toxin-Associated Hemolytic Uremic Syndrome

  • D+ Hus

  • Ehec-Hus

  • Hemolytic Uremic Syndrome Associated With Shiga Toxin-Producing Escherichia Coli

  • Hemolytic Uremic Syndrome With Diarrhea

  • Stec-Hus

  • Shiga-Like Toxin-Associated Hus

  • Stx-Hus

  • Typical Hus

  • Typical Hemolytic Uremic Syndrome

  • Atypical Hemolytic Uremic Syndrome With Anti-Factor H Antibodies

  • Atypical Hus With Anti-Factor H Antibodies

  • Ahus With Anti-Factor H Antibodies

  • Ahus With Neutralizing Autoantibodies Against Factor H

  • Hemolytic Uremic Syndrome Atypical 1

  • Atypical Hemolytic Uremic Syndrome With H Factor Anomaly

  • D Hus

  • Hemolytic-Uremic Syndrome Without Diarrhea

  • Hemolytic-Uremic Syndrome, Atypical, Type 1

  • Hemolytic Uremic Syndrome, Typical
Systemic Lupus Erythematosus

  • Lupus Nephritis

  • SLE

  • Disseminated Lupus Erythematosus

  • Systemic Lupus Erythematosus, Susceptibility To

  • Lupus Erythematosus, Systemic

  • Lupus Nephritis, Susceptibility To

  • Libman-Sacks Disease

  • Systemic Lupus Erythematosus Susceptibility To

  • Sle - Lupus Erythematosus, Systemic

  • Le Syndrome

  • Lupus

  • Lupus Erythematosus Systemic

  • Lupus Erythematosus, Systemic, Susceptibility To

  • Lupus Vulgaris

  • Lupus Erythematosus, Discoid

  • Lupus Erythematosus

  • Systemic Lupus Erythematosus Nos

  • Sle - [Systemic Lupus Erythematosus]
Macular Degeneration, Age-Related, 1

  • Macular Degeneration

  • Age-Related Macular Degeneration

  • Macular Degeneration, Age-Related

  • Age Related Macular Degeneration

  • Age Related Macular Degeneration 1

  • ARMD1

  • Senile Macular Degeneration

  • Maculopathy, Age-Related, 1

  • Macular Degeneration, Age-Related, Reduced Risk Of

  • Age Related Maculopathy 1

  • Age Related Maculopathies

  • Age Related Maculopathy

  • Senile Macular Retinal Degeneration

  • Macular Degeneration Of Retina

  • Age-Related Maculopathy

  • Amd

  • Armd

  • Age-Related Maculopathy, Susceptibility To

  • Maculopathy Age-Related

  • Macular Degeneration, Age-Related, 1, Susceptibility To

  • Maculopathy, Age-Related

  • Macular Degeneration, Age-Related, Type 1

  • Macular Degeneration, Age-Related, 2
Membranoproliferative Glomerulonephritis

  • Mesangiocapillary Glomerulonephritis

  • Dense Deposit Disease

  • Membranoproliferative Glomerulonephritis Type 2

  • Primary Membranoproliferative Glomerulonephritis

  • Mesangiocapillary Glomerulonephritis, Type Ii

  • Glomerulonephritis, Membranoproliferative

  • Chronic Glomerulonephritis, Lobular

  • Lobular Glomerulonephritis

  • Ddd

  • Glomerulonephritis Membranoproliferative Type 2

  • Mpgn 2

  • Membranoproliferative Glomerulonephritis Type Ii

  • Mesangiocapillary Glomerulonephritis Type 2

  • Mpgn

  • Primary Mpgn

  • Glomerulonephritis Membranoproliferative

  • Membranoproliferative Glomerulonephritis, Type Ii
Diseases Alias
Waldenstroem'S Macroglobulinemia

Waldenstroem'S Macroglobulinemia

Waldenstroem'S Macroglobulinemia

Macroglobulinemia Of Waldenstrom

Lymphoplasmacytic Lymphoma With Igm Gammopathy

Lymphoplasmacytic Lymphoma

Waldenstroem'S Macroglobulinemia

Waldenstroem'S Macroglobulinemia

Macroglobulinemia Of Waldenstrom

Lymphoplasmacytic Lymphoma With Igm Gammopathy

Lymphoplasmacytic Lymphoma

Related Agents

  • Approval
  • Clinical Phase
  • Pre-clinical Phase

Approval

Bioactive Molecules (10)
Cat. No. Product Name Effect
Purity Rare Diseases
HY-14541 Olanzapine 99.96% Yes
HY-17627 Avacopan Inhibitor 98.50% Yes
HY-147080 Avacincaptad pegol sodium Inhibitor 94.64% Unkown
HY-P3502 Zilucoplan Inhibitor 99.71% Unkown
HY-B1213 Trimipramine maleate 99.88% Unkown
HY-B2169 Melperone 99.84% Yes
HY-148457 Avacincaptad pegol Inhibitor 92.50% Unkown
HY-14541R Olanzapine (Standard) 99.98% Unkown
HY-B1213A Trimipramine / Unkown
HY-P3502A Zilucoplan TFA Inhibitor / Unkown
Inhibitory Antibodies (5)
Cat. No. Product Name Effect
Purity Rare Diseases
HY-P9914 Eculizumab Inhibitor 99.88% Unkown
HY-P99394 Talquetamab 96.44% Unkown
HY-P99365 Ravulizumab Inhibitor 95.57% Unkown
HY-P99965 Crovalimab Inhibitor 99.59% Unkown
HY-P99786 Pozelimab Inhibitor 99.42% Unkown

Clinical Phase

Bioactive Molecules (12)
Cat. No. Product Name Effect
Purity Phase
HY-E70206 CpG Methyltransferase / Phase 4
HY-14541A Olanzapine hydrochloride / Phase 4
HY-145720 Cemdisiran Inhibitor 98.43% Phase 3
HY-145720A Cemdisiran sodium 96.30% Phase 3
HY-103109 Melperone hydrochloride / Phase 3
HY-P10653 C5A Inhibitor / Phase 3
HY-106178 PMX-53 Antagonist 99.95% Phase 2
HY-111200 Vabicaserin hydrochloride Agonist 99.47% Phase 2
HY-105277 Amesergide Antagonist / Phase 2
HY-19283 DU125530 Antagonist / Phase 2
HY-W008820 Glutaric acid 98.44% Phase 1
HY-123044 Tedatioxetine Antagonist / Phase 1
Inhibitory Antibodies (11)
Cat. No. Product Name Effect
Purity Phase
HY-P99520 Vilobelimab Inhibitor 99.27% Phase 3
HY-P99638 Gefurulimab Inhibitor 97.88% Phase 3
HY-P99886 Pexelizumab Inhibitor 99.0% Phase 3
HY-P99450 Avdoralimab Inhibitor 99.25% Phase 2
HY-P99322 Tesidolumab Inhibitor 98.80% Phase 2
HY-P991022 Ruxoprubart Inhibitor 95.541% Phase 2
HY-P99767 Olendalizumab Inhibitor 97.43% Phase 2
HY-P990753 Omoprubart Inhibitor 97.769% Phase 2
HY-P991067 Vensobafusp alfa Inhibitor 97% Phase 2
HY-P990745 Izastobart Ligand 99% Phase 1
HY-P991657 MEDI7814 Inhibitor / Phase 1

Pre-clinical Phase

Bioactive Molecules (507)
Cat. No. Product Name
Effect
Purity
Rare Diseases
HY-N0390S1 L-Glutamine-13C5 99.93% Unkown
HY-149652 IRF5-IN-1 Inhibitor 99.91% Unkown
HY-128729 DNA2 inhibitor C5 Inhibitor 98.51% Unkown
HY-138161 JR14a Antagonist 99.77% Unkown
HY-103124 DOI hydrochloride Agonist 99.61% Unkown
HY-110136A PMX 205 Trifluoroacetate Antagonist 99.50% Unkown
HY-D1612 BODIPY FL C5-Ceramide 99.65% Unkown
HY-B0228S1 Adenosine-13C5 99.9% Unkown
HY-W013636S 2-Ketoglutaric acid-13C5 99.92% Unkown
HY-NP004 Cobra Venom Factor Activator 99.07% Unkown
HY-110136 PMX 205 Antagonist 99.54% Unkown
HY-14608S3 L-Glutamic acid-13C5,15N 99.9% Unkown
HY-N0092S2 Inosine-13C5 Agonist 99.90% Unkown
HY-N0326S5 L-Methionine-13C5 99.96% Unkown
HY-14608S5 L-Glutamic acid-13C5 99.81% Unkown
HY-126523 N3-C5-NHS ester ≥98.0% Unkown
HY-N0717S6 L-Valine-13C5 99.6% Unkown
HY-Y0252S L-Proline-13C5 99.93% Unkown
HY-148141 JPE-1375 Antagonist 99.96% Unkown
HY-W004710 NH2-C5-NH-Boc 99.59% Unkown
HY-W017018S2 L-Ornithine-1,2,3,4,5-13C5 hydrochloride 99.88% Unkown
HY-N0390S6 L-Glutamine-13C5,15N2 98.0% Unkown
HY-130946 NH2-C5-PEG4-N3-L-Lysine-PEG3-N3 99.42% Unkown
HY-145237 BM213 99.81% Unkown
HY-125876 PROTAC Bcl2 degrader-1 Inhibitor 99.80% Unkown
HY-B0445S NAD+-13C5 ammonium 98.89% Unkown
HY-130703 5-Dehydroepisterol Inhibitor 91.96% Unkown
HY-164088 DBM-C5-VC-PAB-MMAE Inhibitor 99.45% Unkown
HY-16992A W-54011 99.57% Unkown
HY-132248 C5 Lenalidomide Inhibitor 99.62% Unkown
HY-P5506 C5a Receptor agonist, W5Cha Agonist 99.13% Unkown
HY-Y0520S Itaconic acid-13C5 99.22% Unkown
HY-D1610 BODIPY FL C5 99.59% Unkown
HY-Y0252S4 L-Proline-13C5,15N 99.93% Unkown
HY-128342 Complement C5-IN-1 Inhibitor 99.13% Unkown
HY-157080 Dibromomaleimide-C5-COOH 99.40% Unkown
HY-P0014S1 Liraglutide-13C5,15N tetraTFA Agonist 97.74% Unkown
HY-B1511S Cyclic AMP-13C5 97.45% Unkown
HY-B1449S10 Uridine-13C5 99.90% Unkown
HY-D1613 BODIPY FL C5-HPC 99.43% Unkown
HY-151667 Biotin-C5-Azide 98.92% Unkown
HY-N0717S1 L-Valine-13C5,15N 99.64% Unkown
HY-110060 NDT 9513727 Antagonist 99.35% Unkown
HY-N0326S6 L-Methionine-13C5,15N 99.62% Unkown
HY-W040055S Neopterin-13C5 97.53% Unkown
HY-15543A CP-809101 hydrochloride Agonist 98.61% Unkown
HY-W008820S1 Glutaric acid-d4 99.46% Unkown
HY-P10639 C5aR2 agonist P32 Agonist 99.17% Unkown
HY-N0091S2 Hypoxanthine-13C5 99.74% Unkown
HY-122725B Lenalidomide-C5-NH2 hydrochloride 99.28% Unkown
HY-136237 Thalidomide-NH-C5-NH2 hydrochloride Inducer 99.86% Unkown
HY-148671 (S,R,S)-AHPC-amido-C7-acid 98.71% Unkown
HY-W018772S15 D-Ribose(mixture of isomers)-13C5 99.95% Unkown
HY-101324A MK-212 monohydrochloride Agonist 99.69% Yes
HY-141840 GLP-1R modulator C5 Modulator 99.81% Unkown
HY-W008137 5-Bromo-2-fluoropyrimidine 99.70% Unkown
HY-117971 BVT173187 Inhibitor 99.97% Unkown
HY-132141 5-PA-dUTP / Unkown
HY-138848A Thalidomide-4-O-C5-NH2 hydrochloride Inducer 96.87% Unkown
HY-14879S2 Avibactam sodium salt-13C5 Inhibitor 99.9% Unkown
HY-160241 Lenalidomide-C5-acid 96.01% Unkown
HY-B1654S Flavin adenine dinucleotide-13C5 ammonium 90.08% Unkown
HY-113038AS α-Hydroxyglutaric acid-13C5 disodium 99.80% Unkown
HY-137905 Pomalidomide-amido-C5-PEG2-C6-chlorine 98.75% Unkown
HY-W096148 Biotin-C4-amide-C5-NH2 95.0% Unkown
HY-203808 5'-Carboxy-modifier C5 / Unkown
HY-43941 Thalidomide-NH-C5-NH2 TFA 97.02% Unkown
HY-P1033S1 [Pyr1]-Apelin-13, Pro(13C5,15N) TFA 99.85% Unkown
HY-W006057AS16 Sodium 3-methyl-2-oxobutanoate-13C5 99.00% Unkown
HY-W654041 Adenosine monophosphate-13C5 96.33% Unkown
HY-14541S Olanzapine-d3 99.78% Unkown
HY-14608S4 L-Glutamic acid-13C5,15N,d5 99.9% Unkown
HY-155672 JPC0323 Modulator 99.5% Unkown
HY-177094 Izicopan Antagonist / Unkown
HY-178275 Hydrotecan-NH-L-Ala-L-Val-L-Gln(CO-C5-succinimide)-D-glucitol 98.26% Unkown
HY-N0390S3 L-Glutamine-13C5,15N2,d5 99.95% Unkown
HY-R00007 hsa-let-7c-5p mimic 91.21% Unkown
HY-R00540A hsa-miR-30c-5p agomir 96.15% Unkown
HY-RI00007A hsa-let-7c-5p antagomir 99.39% Unkown
HY-RI00408 hsa-miR-200c-5p inhibitor 97.37% Unkown
HY-W010184S 4,6-Dioxoheptanoic acid-13C5 99.8% Unkown
HY-N0322S3 Cholesterol-13C5 Agonist 99.5% Unkown
HY-W010256S3 D-Xylulose-13C5 99.9% Unkown
HY-W779017 Thymidine-13C5 Inhibitor 99.90% Unkown
HY-129608 Lenalidomide-acetylene-C5-COOH 99.26% Unkown
HY-16637S3 Folic acid-13C5 95.22% Unkown
HY-130530 AP-C5 99.30% Unkown
HY-136187A (S,R,S)-AHPC-C5-NH2 dihydrochloride 97.8% Unkown
HY-141902S Fmoc-Glu(OtBu)-OH-13C5,15N 96.0% Unkown
HY-153098A ARC186 sodium Inhibitor 94.13% Unkown
HY-161939 7030B-C5 Inhibitor 99.78% Unkown
HY-170820 XYD049 Inhibitor 99.46% Unkown
HY-172911 SHP2-IN-37 Inhibitor 96.36% Unkown
HY-R00007A hsa-let-7c-5p agomir 99.93% Unkown
HY-R00514 hsa-miR-29c-5p mimic 96.59% Unkown
HY-R01569 hsa-miR-518c-5p mimic 91.42% Unkown
HY-W753593 N4-Acetylcytidine-13C5 95.92% Unkown
HY-113046S 5-Methyltetrahydrofolic acid-13C5 98.09% Unkown
HY-160901 CP-289,503 Inhibitor 98.21% Unkown
HY-136055 (S,R,S)-AHPC-C5-COOH Inhibitor 98.81% Unkown
HY-W040047S Pregnanediol 3-glucuronide-13C5 95.80% Unkown
HY-130798 (S,R,S)-AHPC-amido-C5-acid 99.58% Unkown
HY-130849 (S,R,S)-AHPC-Me-C5-COOH 96.87% Unkown
HY-131889 Thalidomide-O-C5-acid Inducer 95.82% Unkown
HY-101343 RS 39604 Antagonist 98.0% Unkown
HY-101755 Tedatioxetine hydrobromide Antagonist 99.83% Unkown
HY-108372 Boc-C5-O-C5-O-C6-Cl / Unkown
HY-10984S3 Pomalidomide-15N,13C5 Inducer 88.33% Unkown
HY-112199 CP-447697 Antagonist 99.70% Unkown
HY-122725 Lenalidomide-C5-NH2 98.45% Unkown
HY-128848 Pomalidomide-C2-amido-(C1-O-C5-O-C1)2-COOH 93.92% Unkown
HY-131455A Biotin-C1-PEG3-C3-amido-C5-Gly-Arg-Gly-N3 TFA 98.0% Unkown
HY-132856 Lenalidomide-C5-amido-Boc 95.10% Unkown
HY-139336 Pomalidomide-C5-azide 97.46% Unkown
HY-142079 Br-C1-CONH-C5-CO-Val-Cit-PAB-MMAE / Unkown
HY-150918S 5-Methyl-1H-pyrazole-3-propanoic acid-13C5 / Unkown
HY-153098 ARC186 Inhibitor 94.13% Unkown
HY-15401 WAY 163909 Agonist / Unkown
HY-76082S1 L-Pyroglutamic acid-13C5 / Unkown
HY-P4820A SYNV-cyclo(CGGYF) TFA Inhibitor 97.08% Unkown
HY-R00334 hsa-miR-181c-5p mimic 94.04% Unkown
HY-R00408 hsa-miR-200c-5p mimic 95.76% Unkown
HY-R00540 hsa-miR-30c-5p mimic 98.33% Unkown
HY-RI00334 hsa-miR-181c-5p inhibitor 97.20% Unkown
HY-RI00540 hsa-miR-30c-5p inhibitor 96.54% Unkown
HY-RI00540A hsa-miR-30c-5p antagomir 95.34% Unkown
HY-RI00718 hsa-miR-34c-5p inhibitor 98.64% Unkown
HY-RI00718A hsa-miR-34c-5p antagomir 99.11% Unkown
HY-RS01751 C5AR2 Human Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-W008585 Benzo-15-crown-5-ether 99.02% Unkown
HY-W755003 Guanosine-13C5 / Unkown
HY-W767865 Cyclic GMP sodium-13C5 99.03% Unkown
HY-W768324 Ribitol-13C5 99.9% Unkown
HY-W779800 D-α-Hydroxyglutaric acid-13C5 disodium 98.87% Unkown
HY-128729R DNA2 inhibitor C5 (Standard) Inhibitor 97.58% Unkown
HY-135916 Biotin-C5-amino-C5-amino ≥98.0% Unkown
HY-143704S 5-Aminosalicylic acid-13C6 hydrochloride 99.53% Unkown
HY-153785 NH2-C6-ARC186 sodium Inhibitor 92.50% Unkown
HY-159064S DSPSAPVNVT(Val-13C5,15N)R TFA 95.00% Unkown
HY-N0091S Hypoxanthine-13C5,15N4 ≥99.0% Unkown
HY-W028210 O-Phthalimide-C5-acid 98.0% Unkown
HY-W133935S Diethylenetriaminepentaacetic acid-13C5 pentasodium 99.74% Unkown
HY-W157299 2-(Bromomethyl)-1-fluoro-3-methoxybenzene / Unkown
HY-W586819 C5 Lenalidomide-CH3 / Unkown
HY-122725A Lenalidomide-C5-NH2 TFA 98.94% Unkown
HY-141423 Thalidomide-O-amide-C5-NH2 Inducer / Unkown
HY-141423A Thalidomide-O-amide-C5-NH2 TFA Inducer / Unkown
HY-15398S4 Vitamin D3-13C5 / Unkown
HY-175260 ZN-c5 Degrader / Unkown
HY-A0004S Decitabine-13C5 / Unkown
HY-N0437S1 Progesterone-13C5 Agonist / Unkown
HY-W008048S 2',3'-O-Isopropylideneadenosine-13C5 / Unkown
HY-Y1055S4 Guanine-13C5 Chemical 95.0% Unkown
HY-101324 MK-212 Agonist / Unkown
HY-103120 Org37684 Antagonist / Unkown
HY-10446S1 Pralatrexate-13C5,15N Inducer / Unkown
HY-106400 EGIS 11150 Antagonist / Unkown
HY-108487 N-Acetyl-O-phosphono-Tyr-Glu dipentylamide Inhibitor / Unkown
HY-109590S4 Arachidonic acid-13C5 96.6% Unkown
HY-113062S 20α-Dihydroprogesterone-13C5 / Unkown
HY-113209S2 8-Isoprostaglandin F2α-13C5 / Unkown
HY-113266S Valerylcarnitine-d9 / Unkown
HY-113420S2 11-Dehydro-thromboxane B2-13C5 / Unkown
HY-118411S 5-Ethynyl-2'-deoxyuridine-13C1 / Unkown
HY-120498 RS-64459-193 Agonist / Unkown
HY-124117 LY 278584 Antagonist / Unkown
HY-124310 PDE5-IN-6c / Unkown
HY-129085 5-Methyl cromolyn disodium / Unkown
HY-12956S2 Dinoprost-13C5 / Unkown
HY-130712 NH2-C2-amido-C2-Boc / Unkown
HY-132939 2-(2,6-Dioxopiperidin-3-yl)phthalimidine-C5-Br Chemical / Unkown
HY-133411A NH2-O-C5-COOH hydrobromide / Unkown
HY-134737 Boc-NH-PEG1-C5-OH / Unkown
HY-134986 Thalidomide-NH-C5-NH2 Inducer / Unkown
HY-136187 (S,R,S)-AHPC-C5-NH2 / Unkown
HY-138098 Sartorypyrone B / Unkown
HY-138848 Thalidomide-4-O-C5-NH2 Inducer / Unkown
HY-138851 Thalidomide-NH-amido-C5-NH2 Inducer / Unkown
HY-138851A Thalidomide-NH-amido-C5-NH2 hydrochloride Inducer / Unkown
HY-139996 Pomalidomide-C5-Dovitinib / Unkown
HY-141062 N-Methyl-N'-(azido-PEG2-C5)-Cy5 / Unkown
HY-141143 MC(C5)-Val-Cit / Unkown
HY-141593 Modified MMAF-C5-COOH / Unkown
HY-14291S2 Vildagliptin-13C5,15N Inhibitor / Unkown
HY-143340 LEB-03-145 / Unkown
HY-144676 pan-HER-IN-1 / Unkown
HY-14520S1 Tetrahydrofolic acid-13C5 / Unkown
HY-14541S2 Olanzapine-d8 99.9% Unkown
HY-147585 C5aR-IN-1 / Unkown
HY-147586 C5aR-IN-2 / Unkown
HY-147587 C5aR-IN-3 / Unkown
HY-14781S2 Levomefolic acid-13C5 / Unkown
HY-148326 Glu(OtBu)-Val-Cit-PAB-OH / Unkown
HY-148362 Pomalidomide-C6-O-C5-O-C4-COOH 98.55% Unkown
HY-14879S7 Avibactam-13C5,15N sodium / Unkown
HY-149562 Thalidomide-5-O-C5-NH2 hydrochloride Inducer / Unkown
HY-150632 SARS-CoV-2 nsp13-IN-6 Inhibitor / Unkown
HY-150660S Ercalcidiol-13C5 / Unkown
HY-150663S Calcitriol-13C5 / Unkown
HY-153464 CXCR4-IN-1 Inhibitor / Unkown
HY-155186 SARS-CoV-2 3CLpro-IN-19 Inhibitor / Unkown
HY-155261 Pomalidomide-5-C5-NH2 hydrochloride / Unkown
HY-155506 NAMPT degrader-3 Degrader / Unkown
HY-157511 Thalidomide-O-C5-azide / Unkown
HY-157933 SF-C5-TPP / Unkown
HY-158627 JPC0323 Oleate Modulator / Unkown
HY-158992S SP-(Val-13C5,15N)-EKNQ-(Leu-13C6,15N)-TIDFINIVKDPVPHNEYKT TFA / Unkown
HY-159570 XD2-149 / Unkown
HY-159571 Thalidomide-NH-C5-azacyclohexane-N-Boc / Unkown
HY-159572 NH2-C5-Azacyclohexane-N-Boc / Unkown
HY-160077 Pomalidomide-CO-C5-azide / Unkown
HY-161132 Lenalidomide 4'-alkyl-C5-azide / Unkown
HY-161793 (S,R,S)-AHPC-NHCO-C-O-C5-N3 / Unkown
HY-162950 Piperidin-4-amine-C5-O-C1-Thalidomide / Unkown
HY-163378 C5aR1 antagonist 1 Antagonist / Unkown
HY-163379 C5aR1 antagonist 2 Antagonist / Unkown
HY-163788 C5-CONH-C2-N-CH3 / Unkown
HY-164084 DBCO-NHCO-C5-O-phenylethenesulfonyl fluoride / Unkown
HY-164829 Mal-C5-Gly-Gly-Phe-MMAE Inhibitor / Unkown
HY-16567S Asenapine-13C,d3 hydrochloride Antagonist / Unkown
HY-16637S2 (Rac)-Folic acid-13C5,15N / Unkown
HY-16637S4 Folic acid-13C5,15N / Unkown
HY-168039 Boc-NH-Piperidine-C5-OH / Unkown
HY-168040 Thalidomide-O-C5-piperidine-NH-Boc / Unkown
HY-169010 Pomalidomide-CO-C5-Br / Unkown
HY-16938S2 5'-Methylthioadenosine-13C5 / Unkown
HY-172213 (3S,6R)-NML Antagonist / Unkown
HY-172339 4-AcO-DALT hydrochloride Inhibitor / Unkown
HY-172645 (S,R,S)-AHPC-Me-amide-C-O-C5-Br / Unkown
HY-173010 Me-(S,R,S)-AHPC-CO-C5-N3 / Unkown
HY-173419 5-cis-15(R)-Iloprost / Unkown
HY-17383S Levomefolate-13C5 calcium Chemical / Unkown
HY-174898 5-HT2C agonist-9 Agonist / Unkown
HY-175890 DDB1 ligand-2 / Unkown
HY-175981 Paclitaxel-bromothiophene / Unkown
HY-176277S Fibrinopeptide B, human-(Val-13C5,15N, Arg-13C6,15N4) TFA / Unkown
HY-17627S1 Avacopan-d4 Inhibitor / Unkown
HY-176794 Phenyl-glutarimide 4'-oxyacetic-amide-C5-amide-Boc / Unkown
HY-178630S 2-Hydroxy-5-oxotetrahydrofuran-2-carboxylic acid-13C5 / Unkown
HY-180946 AChE-IN-105 Inhibitor / Unkown
HY-181058 Cyclopamine-COO-2-ethoxy-1,3-benzodioxole-O-C-Triazole-C5-AC / Unkown
HY-181312 CRBN ligand-225-C5-O-C5-NH2 / Unkown
HY-18252S1 Avanafil-13C5,15N,d2 / Unkown
HY-183083 CDK7 ligand 3-CO-C5-COOH Ligand / Unkown
HY-183414 C5aR antagonist-1 Antagonist / Unkown
HY-183844 C5F2-HCB / Unkown
HY-184548 (S,R,S)-AHPC-CO-PEG2-C5-TsO / Unkown
HY-184672 Thalidomide-NH-C2-NH-C5-NH2 / Unkown
HY-21994 Org-12962 hydrochloride Agonist / Unkown
HY-32351AS1 Calcifediol-13C5 monohydrate / Unkown
HY-50719S1 2-Acetyl-1-pyrroline-13C5 / Unkown
HY-A0003S2 Lenalidomide-13C5,15N Inducer / Unkown
HY-B0152S2 Adenine-13C5,15N5 Chemical 95% Unkown
HY-B0434S Ribavirin-13C5 Inhibitor / Unkown
HY-B0456S2 Riboflavin-13C5 / Unkown
HY-B0660S1 Eicosapentaenoic acid 1,2,3,4,5-13C5 Activator / Unkown
HY-B1204S2 Histamine-13C5, 15N3 / Unkown
HY-B1346S DL-Glutamine-13C5,15N2,d10 / Unkown
HY-D1592 BODIPY TMR C5-maleimide / Unkown
HY-D1611 BODIPY FL-C5 NHS Ester / Unkown
HY-D3573 AF488 C5 Maleimide / Unkown
HY-D3576 AF532 C5 Maleimide / Unkown
HY-D3579 AF568 C5 Maleimide / Unkown
HY-D3580 AF594 C5 Maleimide / Unkown
HY-D3582 AF633 C5 Maleimide / Unkown
HY-E71077 (5R)-Carbapenem-3-carboxylate synthase / Unkown
HY-E71200E 16S rRNA (cytosine1407-C5)-Methyltransferase / Unkown
HY-E71200H 16S rRNA (cytosine967-C5)-Methyltransferase / Unkown
HY-E71422 2,3-Dimethylmalate lyase / Unkown
HY-E71453J 23S rRNA (cytosine1962-C5)-Methyltransferase / Unkown
HY-E71453U 23S rRNA (uracil1939-C5)-Methyltransferase / Unkown
HY-E71453V 23S rRNA (uracil747-C5)-Methyltransferase / Unkown
HY-E71459B 25S rRNA (cytosine2278-C5)-Methyltransferase / Unkown
HY-E71459C 25S rRNA (cytosine2870-C5)-Methyltransferase / Unkown
HY-I1111S3 Fmoc-L-Val-OH-13C5 / Unkown
HY-N0210S4 D-Galactose-13C-5 99.80% Unkown
HY-N0379S10 D-Mannose-13C-5 99.83% Unkown
HY-N0717S2 L-Valine-13C5,15N,d8 99.3% Unkown
HY-N0717S3 L-Valine-13C5,15N,d2 / Unkown
HY-N12728 Heteroclitin G / Unkown
HY-N13081 3-Oxo-cinobufagin / Unkown
HY-N19183 C5-O-Demethyl K41-A Inhibitor / Unkown
HY-N3406 Lansiumarin C / Unkown
HY-N7082S D-Arabinopyranose-13C5 99.9% Unkown
HY-P10274 CM05 Inhibitor / Unkown
HY-P4820 SYNV-cyclo(CGGYF) Inhibitor / Unkown
HY-P4971 C5a Anaphylatoxin (human) Modulator / Unkown
HY-P5081 Endotrophin (Mus musculus) Activator / Unkown
HY-P60514S1 NQVS-(Leu-13C6,15N)-SCA-(Val-13C5,15N)-K TFA / Unkown
HY-P60515S1 NQVSLWC-(Leu-13C6,15N)-(Val-13C5,15N)-K TFA / Unkown
HY-P60516S ASQDISSA-(Leu-13C6,15N)-(Val-13C5,15N)-WYQQKPGK TFA / Unkown
HY-R00334A hsa-miR-181c-5p agomir / Unkown
HY-R00408A hsa-miR-200c-5p agomir / Unkown
HY-R00514A hsa-miR-29c-5p agomir / Unkown
HY-R00718 hsa-miR-34c-5p mimic / Unkown
HY-R00718A hsa-miR-34c-5p agomir / Unkown
HY-R00833 hsa-miR-374c-5p mimic / Unkown
HY-R00833A hsa-miR-374c-5p agomir / Unkown
HY-R00841 hsa-miR-376c-5p mimic / Unkown
HY-R00841A hsa-miR-376c-5p agomir / Unkown
HY-R01113 hsa-miR-449c-5p mimic / Unkown
HY-R01113A hsa-miR-449c-5p agomir / Unkown
HY-R01547 hsa-miR-513c-5p mimic / Unkown
HY-R01547A hsa-miR-513c-5p agomir / Unkown
HY-R01569A hsa-miR-518c-5p agomir / Unkown
HY-R02507 hsa-miR-892c-5p mimic / Unkown
HY-R02507A hsa-miR-892c-5p agomir / Unkown
HY-R02796 mmu-miR-1970c-5p mimic / Unkown
HY-R02796A mmu-miR-1970c-5p agomir / Unkown
HY-R02834 mmu-miR-216c-5p mimic / Unkown
HY-R02834A mmu-miR-216c-5p agomir / Unkown
HY-R02841 mmu-miR-219c-5p mimic / Unkown
HY-R02841A mmu-miR-219c-5p agomir / Unkown
HY-R02883 mmu-miR-297c-5p mimic / Unkown
HY-R02883A mmu-miR-297c-5p agomir / Unkown
HY-R02898 mmu-miR-302c-5p mimic / Unkown
HY-R02898A mmu-miR-302c-5p agomir / Unkown
HY-R03044 mmu-miR-344c-5p mimic / Unkown
HY-R03044A mmu-miR-344c-5p agomir / Unkown
HY-R03105 mmu-miR-374c-5p mimic / Unkown
HY-R03105A mmu-miR-374c-5p agomir / Unkown
HY-R03112 mmu-miR-376c-5p mimic / Unkown
HY-R03112A mmu-miR-376c-5p agomir / Unkown
HY-R03149 mmu-miR-449c-5p mimic / Unkown
HY-R03149A mmu-miR-449c-5p agomir / Unkown
HY-R03164 mmu-miR-465c-5p mimic / Unkown
HY-R03164A mmu-miR-465c-5p agomir / Unkown
HY-R03171 mmu-miR-466c-5p mimic / Unkown
HY-R03171A mmu-miR-466c-5p agomir / Unkown
HY-R03199 mmu-miR-467c-5p mimic / Unkown
HY-R03199A mmu-miR-467c-5p agomir / Unkown
HY-R03461 mmu-miR-669c-5p mimic / Unkown
HY-R03461A mmu-miR-669c-5p agomir / Unkown
HY-R04278 rno-miR-196c-5p mimic / Unkown
HY-R04278A rno-miR-196c-5p agomir / Unkown
HY-R04285 rno-miR-200c-5p mimic / Unkown
HY-R04285A rno-miR-200c-5p agomir / Unkown
HY-R04448 rno-miR-376c-5p mimic / Unkown
HY-R04448A rno-miR-376c-5p agomir / Unkown
HY-R04485 rno-miR-466c-5p mimic / Unkown
HY-R04485A rno-miR-466c-5p agomir / Unkown
HY-RI00007 hsa-let-7c-5p inhibitor / Unkown
HY-RI00334A hsa-miR-181c-5p antagomir / Unkown
HY-RI00408A hsa-miR-200c-5p antagomir / Unkown
HY-RI00514 hsa-miR-29c-5p inhibitor / Unkown
HY-RI00514A hsa-miR-29c-5p antagomir / Unkown
HY-RI00833 hsa-miR-374c-5p inhibitor / Unkown
HY-RI00833A hsa-miR-374c-5p antagomir / Unkown
HY-RI00841 hsa-miR-376c-5p inhibitor / Unkown
HY-RI00841A hsa-miR-376c-5p antagomir / Unkown
HY-RI01113 hsa-miR-449c-5p inhibitor / Unkown
HY-RI01113A hsa-miR-449c-5p antagomir / Unkown
HY-RI01547 hsa-miR-513c-5p inhibitor / Unkown
HY-RI01547A hsa-miR-513c-5p antagomir / Unkown
HY-RI01569 hsa-miR-518c-5p inhibitor / Unkown
HY-RI01569A hsa-miR-518c-5p antagomir / Unkown
HY-RI02507 hsa-miR-892c-5p inhibitor / Unkown
HY-RI02507A hsa-miR-892c-5p antagomir / Unkown
HY-RI02796 mmu-miR-1970c-5p inhibitor / Unkown
HY-RI02796A mmu-miR-1970c-5p antagomir / Unkown
HY-RI02834 mmu-miR-216c-5p inhibitor / Unkown
HY-RI02834A mmu-miR-216c-5p antagomir / Unkown
HY-RI02841 mmu-miR-219c-5p inhibitor / Unkown
HY-RI02841A mmu-miR-219c-5p antagomir / Unkown
HY-RI02883 mmu-miR-297c-5p inhibitor / Unkown
HY-RI02883A mmu-miR-297c-5p antagomir / Unkown
HY-RI02898 mmu-miR-302c-5p inhibitor / Unkown
HY-RI02898A mmu-miR-302c-5p antagomir / Unkown
HY-RI03044 mmu-miR-344c-5p inhibitor / Unkown
HY-RI03044A mmu-miR-344c-5p antagomir / Unkown
HY-RI03105 mmu-miR-374c-5p inhibitor / Unkown
HY-RI03105A mmu-miR-374c-5p antagomir / Unkown
HY-RI03112 mmu-miR-376c-5p inhibitor / Unkown
HY-RI03112A mmu-miR-376c-5p antagomir / Unkown
HY-RI03149 mmu-miR-449c-5p inhibitor / Unkown
HY-RI03149A mmu-miR-449c-5p antagomir / Unkown
HY-RI03164 mmu-miR-465c-5p inhibitor / Unkown
HY-RI03164A mmu-miR-465c-5p antagomir / Unkown
HY-RI03171 mmu-miR-466c-5p inhibitor / Unkown
HY-RI03171A mmu-miR-466c-5p antagomir / Unkown
HY-RI03199 mmu-miR-467c-5p inhibitor / Unkown
HY-RI03199A mmu-miR-467c-5p antagomir / Unkown
HY-RI03461 mmu-miR-669c-5p inhibitor / Unkown
HY-RI03461A mmu-miR-669c-5p antagomir / Unkown
HY-RI04278 rno-miR-196c-5p inhibitor / Unkown
HY-RI04278A rno-miR-196c-5p antagomir / Unkown
HY-RI04285 rno-miR-200c-5p inhibitor / Unkown
HY-RI04285A rno-miR-200c-5p antagomir / Unkown
HY-RI04448 rno-miR-376c-5p inhibitor / Unkown
HY-RI04448A rno-miR-376c-5p antagomir / Unkown
HY-RI04485 rno-miR-466c-5p inhibitor / Unkown
HY-RI04485A rno-miR-466c-5p antagomir / Unkown
HY-RS01749 C5 Human Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS01750 C5AR1 Human Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS12597 SDR16C5 Human Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-W000450S 5-Aminolevulinic acid-13C / Unkown
HY-W007035S H-Val-Ala-OH-13C5,15N TFA / Unkown
HY-W008371S1 Fmoc-Met-OH-13C5,15N 99.8% Unkown
HY-W008820S2 Glutaric acid-d2 / Unkown
HY-W009538S1 5'-Deoxy-5-fluorocytidine-13C5 / Unkown
HY-W010918S3 Adenosine 5'-diphosphate-13C5 / Unkown
HY-W016145S L-Glutamic acid-13C5 hydrate salt / Unkown
HY-W016785S Glycyl-L-valine-13C5,15N TFA / Unkown
HY-W017401S Benzisothiazolinone-13C6 Inhibitor / Unkown
HY-W096134 Benzyloxy-C5-PEG1 / Unkown
HY-W143131S Diethyl itaconate,98% (stabilized with TBC)-13C5 / Unkown
HY-W392941 Naphtho[1,2-c:5,6-c']difuran-1,3,6,8-tetraone / Unkown
HY-W400722 Sodium 3-methyl-2-oxobutanoate-13C5,d1 / Unkown
HY-W746880 D-Arabinose Phenylhydrazone-13C5 / Unkown
HY-W749825 Pentetic acid-13C5 / Unkown
HY-W750576 4-Octyl itaconate-13C5 / Unkown
HY-W751746 Dehydro Folic Acid 1,5-Dimethyl Ester-13C5 / Unkown
HY-W751764 Dehydro Folic Acid 1,5-Dimethyl Ester-13C5,15N / Unkown
HY-W753201 5'-Methylthioadenosine-13C / Unkown
HY-W754064 Cytidine-5'-triphosphate-13C5 / Unkown
HY-W756758 Guanosine-13C5 5'-Monophosphate / Unkown
HY-W768207 Cytidine-1',2',3',4',5'-13C5 / Unkown
HY-W768213 2'-Deoxyguanosine monohydrate-13C5 / Unkown
HY-W768275 Glucopyranose-13C5 / Unkown
HY-W768283 Guanosine Hydrate-13C5 / Unkown
HY-W768302 D-Lyxose-13C5 / Unkown
HY-W768333 D-Ribofuranose-13C5 97.0% Unkown
HY-W768347 Xylitol-13C5 / Unkown
HY-W769288 Pemetrexed disodium-13C5 / Unkown
HY-W769319 Inosinic acid-13C5 / Unkown
HY-W769319A Inosinic acid-13C5 TEA / Unkown
HY-W777286 rac-Lenalidomide-13C5 / Unkown
HY-W778990 2-Deoxyuridine-1,2,3,4,5-13C5 / Unkown
HY-W783407S1 Ac-rG Phosporamidite-13C / Unkown
HY-W877850 Mal-C5-N-bis(PEG2-C2-acid) 96.25% Unkown
HY-W935330 Thalidomide-ethyne-C5-COOH / Unkown
HY-W998329 Thalidomide-O-amide-C5-NH2 hydrochloride Inducer 95.51% Unkown
HY-Y1055S2 Guanine-13C5,15N5 Chemical / Unkown
HY-Y1166S N-(9-Fluorenylmethoxycarbonyl)glutamic acid α-tert-butyl ester-13C5,15N / Unkown
HY-100805S1 D-Glutamic acid-13C5,15N / Unkown
HY-100805S2 D-Glutamic acid-13C5 / Unkown
HY-101324AR MK-212 monohydrochloride (Standard) Agonist / Unkown
HY-106178D PMX 53 monoacetate / Unkown
HY-10984S4 Pomalidomide-13C5 Inducer / Unkown
HY-112675S 4-Octyl itaconate-13C5-1 / Unkown
HY-117872 Sartorypyrone A / Unkown
HY-13599S1 Cladribine-13C5,15N2 / Unkown
HY-144345S L-γ-Glutamyl-L-cysteinyl-L-lysine-13C5,15N / Unkown
HY-147338S1 5-Methylcytidine 5′-triphosphate-15N2,13C trisodium / Unkown
HY-149691 O-Phthalimide-C1-S-C5-acid / Unkown
HY-149751 Methylthiomcresol-C5-COOH / Unkown
HY-150661S 3-epi-Calcifediol-13C5 / Unkown
HY-15401A WAY 163909 (hydrochloride) Agonist / Unkown
HY-154069 N-Trityl-N4-benzoyl-morpholino-C-5’-O-phosphoramidite / Unkown
HY-15543 CP-809101 Agonist / Unkown
HY-157472 ACT-1014-6470 Antagonist / Unkown
HY-158382 NH2-C4-PEG4-C5-COOH / Unkown
HY-159046S ASGITFSNSGMHW(Val-13C5,15N)R TFA / Unkown
HY-159065S FIQE(Val-13C5,15N)NTTTR TFA / Unkown
HY-160235 Pomalidomide-C2-amide-C5-azide / Unkown
HY-161792 N3-C5-O-C-Boc / Unkown
HY-162948 (S,R,S)-AHPC-PEG2-C5-N3 / Unkown
HY-162949 Piperidin-4-amine-C5-O-C1 / Unkown
HY-16384 L-156602 Antagonist / Unkown
HY-170796 α-Amylase-IN-11 Inhibitor / Unkown
HY-173102S LQEEIDAVL(Pro-13C5,15N)NK TFA / Unkown
HY-173105S TPEEAHALSA(Pro-13C5,15N)TSR TFA / Unkown
HY-173514 SARS-CoV-2 Mpro-IN-42 Inhibitor / Unkown
HY-175260A ZN-c5 hydrochloride Degrader / Unkown
HY-176179S LFFAADHLV(Val-13C5,15N)CE / Unkown
HY-176336 Thalidomide-C-amide-C5-amine / Unkown
HY-176883 Inositol phosphate amide-C5-NH2 / Unkown
HY-177942 Azide-C5-amide-tri-SA-bis(amide-PBA) / Unkown
HY-179849 BODIPY-butyramide-C5-COO-Lyso PI ammonium / Unkown
HY-18206S2 Lisinopril-13C5,15N / Unkown
HY-18252S3 Avanafil-13C5 / Unkown
HY-186237 Fuc(1→2)-Gal(3→1)(C3-amide-C5-biotin)-GalNAc / Unkown
HY-403544 CbzNH-(C5-O)2-C4-Boc / Unkown
HY-B0152S3 Adenine-13C5 Chemical / Unkown
HY-B0368S1 Captopril-13C5,15N Inhibitor / Unkown
HY-B0511S3 Biotin-13C5 / Unkown
HY-B1213S Trimipramine-d3 maleate / Unkown
HY-B2169S2 Melperone-d4 hydrochloride 99.84% Unkown
HY-I1111S2 Fmoc-L-Val-OH-13C5,15N 98% Unkown
HY-P10639A C5aR2 agonist P32 acetate Agonist / Unkown
HY-P3502B Zilucoplan (PEG2) Inhibitor / Unkown
HY-RS18377 C5ar1 Mouse Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS22969 C5 Rat Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS24857 C5ar1 Rat Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-W010450S5 Thymine-13C5,15N2 / Unkown
HY-W011297S3 Methyl arachidonate-13C5 / Unkown
HY-W013780S1 Fmoc-Pro-OH-13C5,15N Inhibitor / Unkown
HY-W039426 N-Trityl-N4-benzoyl-morpholino-C-5'-O-phosphoramidite / Unkown
HY-W1130286 NH2-C6-O-C5-O-C4-COOH / Unkown
HY-W130878 4-Octylphenol Activator / Unkown
HY-W251144 N,N′-Dipentyl-3,4,9,10-perylenedicarboximide / Unkown
HY-W338810S S-(5'-Adenosyl)-L-methionine-13C5 sulfate / Unkown
HY-W369104 Boc-MeN-C5-OH / Unkown
HY-W396031 Boc-NH-C5-NH-Me / Unkown
HY-W598206 (S,R,S)-AHPC-PEG8-NH2 hydrochloride / Unkown
HY-W688682 (S,R,S)-AHPC-C5-NH2 hydrochloride / Unkown
HY-W728005 Covidcil-19 Inhibitor / Unkown
HY-W778183 3,5,6-Trichloro-2-pyridinol-13C5 / Unkown
HY-W778207 2'-Deoxyadenosine-13C5 monohydrate / Unkown
HY-W779015 5-Methyluridine-13C5 / Unkown
HY-W779019 Xylose-13C5 / Unkown
HY-W814363 Octadec-9-enoic acid-13C5 / Unkown
HY-W838632 Antibacterial agent 266 Inhibitor 99.46% Unkown
HY-W945790 Thalidomide-4-O-C5-Br / Unkown
HY-W949165 C5 Lenalidomide-6-fluoro / Unkown
HY-W998298 (S,R,S)-AHPC-C5-PEG3-C3 / Unkown
HY-W013081S Fmoc-Gln(Trt)-OH-13C5,15N2 / Unkown
Inhibitory Antibodies (11)
Cat. No. Product Name
Effect
Purity
Rare Diseases
HY-P990608 Alpitatug 99.13% Unkown
HY-P990955 Ebribafusp alfa Inhibitor 96.40% Unkown
HY-P992102 Ascuprubart Inhibitor 97.89% Unkown
HY-P992111 Elfritatug Inhibitor 98.98% Unkown
HY-P990998 Greziprubart Inhibitor 97.79% Unkown
HY-P992014 Anti-Human/Mouse/Monkey CXCR3 Antibody (9C5) Inhibitor 99.33% Unkown
HY-P991485 Anti-CD88/C5AR1 Antibody (G2_anti-C5aR) Inhibitor / Unkown
HY-P991788 Anti-Mouse CCR5 Antibody (C5Mab-2) Inhibitor / Unkown
HY-P991811 Anti-Mouse IFN Alpha Antibody (TIF-3C5) Inhibitor / Unkown
HY-P991796 Anti-Mouse C5aR Antibody (20/70) Inhibitor / Unkown
HY-P992215 Anti-CD85a/LILRB3 Antibody (7C5) / Unkown

Orthologs Information

Species Symbol Source ID
Felis catus C5 VGNC VGNC:60232
Bos taurus C5 VGNC VGNC:49997
Macaca mulatta C5 VGNC VGNC:70475
Canis familiaris C5 VGNC VGNC:38595
Rattus norvegicus C5 RGD RGD:2237
Mus musculus C5 MGD MGI:96031
Others C5 NCBI